Further support to the link between Th17 cells, IL-17 and MS relapses comes from the observation that human Th17 cells are able to cross the blood-brain barrier (BBB) in MS lesions, enhancing neuroinflammation (Kebir et al., 2007). The gene discussed is IL17A; the disease is myeloid sarcoma.